Premium
DT‐02‐02: NOVEL ULTRASENSITIVE IMMUNOASSAY DETECTING P‐TAU THR217 COMPLETELY DISTINGUISHES ALZHEIMER'S DISEASE FROM FRONTOTEMPORAL LOBAR DEGENERATION
Author(s) -
Hanes Jozef,
Kontsekova Eva,
Kovac Andrej,
Katina Stanislav,
Teunissen Charlotte E.,
Vyhnalek Martin,
Hort Jakub,
Zilka Norbert,
Scheltens Philip
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.07.011
Subject(s) - immunoassay , frontotemporal lobar degeneration , biomarker , cerebrospinal fluid , tau protein , immunohistochemistry , microbiology and biotechnology , western blot , medicine , antibody , monoclonal antibody , pathology , chemistry , gastroenterology , alzheimer's disease , frontotemporal dementia , immunology , biology , disease , dementia , biochemistry , gene
rating 6 appropriate and 8 inappropriate. Conclusions: In anticipation of the emergence of more reliable CSF analysis platforms, this presentation will provide the Alzheimer’s research community the first opportunity to review the AUC in detail. A full manuscript will also be published in the near future. The manuscript offers important guidance to healthcare practitioners, and suggestions for implementation and future research.